Actively Recruiting

Phase Not Applicable
Age: 3Months - 18Years
MALE
NCT03180918

Male Fertility Preservation Using Cryopreservation of Testicular Tissue Before Highly Gonadotoxic Cancer Treatment

Led by Gumy-Pause Fabienne · Updated on 2022-11-02

100

Participants Needed

3

Research Sites

4435 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Background: Due to the remarkable improvement in treatments these last decades, long term survival can be expected in more than 80% of childhood cancer patients. Unfortunately, cancer treatments can be harmful to the gonads and can affect reproductive and endocrine functions. While loss of fertility is a major concern for most patients, sperm cryopreservation should be offered to all pubertal male patients. For prepubertal boys, only the experimental option of testicular biopsy in order to cryopreserve testicular stem cells can be proposed. Primary aims \- To cryopreserve testicular tissue of prepubertal patient receiving highly gonadotoxic oncological treatment. Secondary aims * To cryopreserve testicular tissue after failure of sperm cryopreservation in pubertal patient with high risk of infertility * To create a database in order to record clinical and biological follow-up data * To create a research biobank for future research projects Multicentric study: HUG, CHUV, UKBB

CONDITIONS

Official Title

Male Fertility Preservation Using Cryopreservation of Testicular Tissue Before Highly Gonadotoxic Cancer Treatment

Who Can Participate

Age: 3Months - 18Years
MALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Prepubertal patients aged 3 months and older
  • Peri- and pubertal patients after failure of sperm cryopreservation
  • Patients at high risk of infertility due to gonadotoxic treatments such as high doses of alkylating agents, testicular irradiation, or total body irradiation
  • Multidisciplinary team agrees to propose testicular tissue cryopreservation
Not Eligible

You will not qualify if you...

  • Patients younger than 3 months
  • Patient or parents refuse participation
  • Treatments are not highly gonadotoxic

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 3 locations

1

UKBB

Basel, Switzerland

Actively Recruiting

2

Geneva University Hospitals

Geneva, Switzerland, 1211

Actively Recruiting

3

CHUV

Lausanne, Switzerland

Actively Recruiting

Loading map...

Research Team

F

Fabienne Gumy-Pause, Dr

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

PREVENTION

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here